Tag: FDA inspections
23
MayChinese Generic Production: Manufacturing and Quality Concerns
China supplies 80% of global API, raising quality and supply chain concerns. Explore FDA inspection gaps, purity issues, and the push for diversification in 2026.
2
FebruaryQuality concerns: when clinicians question generic manufacturing
Clinicians are raising alarms about the quality of generic drugs made overseas, especially in India and China. Studies show higher rates of adverse events, supply chain risks, and inspection gaps-raising urgent questions about safety, transparency, and the future of affordable medicine.
Recent posts
-
29 Oct 2025
How Tolvaptan Affects Blood Pressure in Kidney Disease Patients
-
18 May 2026
Protein Shakes and Levothyroxine: The 4-Hour Rule for Safe Timing
-
14 Feb 2026
Antihistamines: First-Generation vs. Second-Generation Compared
-
28 Apr 2026
Seasonal Affective Disorder: How Light Therapy Fights Winter Depression
-
3 Feb 2026
Cervical Myelopathy: Recognizing Spinal Stenosis Symptoms and When Surgery Is Needed